CN114014802A - 一种钯催化剂脱氢偶联合成烯酰胺的方法 - Google Patents
一种钯催化剂脱氢偶联合成烯酰胺的方法 Download PDFInfo
- Publication number
- CN114014802A CN114014802A CN202110873327.XA CN202110873327A CN114014802A CN 114014802 A CN114014802 A CN 114014802A CN 202110873327 A CN202110873327 A CN 202110873327A CN 114014802 A CN114014802 A CN 114014802A
- Authority
- CN
- China
- Prior art keywords
- enamide
- synthesizing
- coupling
- dehydrogenation
- palladium catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 125000005610 enamide group Chemical group 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000003054 catalyst Substances 0.000 title claims abstract description 22
- 238000005859 coupling reaction Methods 0.000 title claims abstract description 22
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 21
- 238000006356 dehydrogenation reaction Methods 0.000 title claims abstract description 20
- 229910052763 palladium Inorganic materials 0.000 title claims abstract description 18
- 238000010168 coupling process Methods 0.000 title claims abstract description 17
- 230000008878 coupling Effects 0.000 title claims abstract description 15
- -1 2-pyridone compound Chemical class 0.000 claims abstract description 22
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims abstract description 17
- 239000007800 oxidant agent Substances 0.000 claims abstract description 10
- 230000001590 oxidative effect Effects 0.000 claims abstract description 10
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims abstract description 9
- 230000009471 action Effects 0.000 claims abstract description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
- 238000004440 column chromatography Methods 0.000 claims description 13
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 5
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims description 5
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940071536 silver acetate Drugs 0.000 claims description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 2
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 claims description 2
- 229940019931 silver phosphate Drugs 0.000 claims description 2
- 229910000161 silver phosphate Inorganic materials 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 15
- 239000012847 fine chemical Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 38
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 18
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 238000001914 filtration Methods 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 1
- QMGHHBHPDDAGGO-IIWOMYBWSA-N (2S,4R)-1-[(2S)-2-[[2-[3-[4-[3-[4-[[5-bromo-4-[3-[cyclobutanecarbonyl(methyl)amino]propylamino]pyrimidin-2-yl]amino]phenoxy]propoxy]butoxy]propoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide Chemical compound CN(CCCNC1=NC(NC2=CC=C(OCCCOCCCCOCCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C=C3)C3=C(C)N=CS3)C(C)(C)C)C=C2)=NC=C1Br)C(=O)C1CCC1 QMGHHBHPDDAGGO-IIWOMYBWSA-N 0.000 description 1
- WHQUHTXULUACFD-KRWDZBQOSA-N (3s)-4-[[2-(4-fluoro-3-methylphenyl)-4-methyl-6-propan-2-ylphenyl]methoxy-hydroxyphosphoryl]-3-hydroxybutanoic acid Chemical compound CC(C)C1=CC(C)=CC(C=2C=C(C)C(F)=CC=2)=C1COP(O)(=O)C[C@@H](O)CC(O)=O WHQUHTXULUACFD-KRWDZBQOSA-N 0.000 description 1
- MNIPVWXWSPXERA-IDNZQHFXSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecanoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)CCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 MNIPVWXWSPXERA-IDNZQHFXSA-N 0.000 description 1
- QLVGHFBUSGYCCG-UHFFFAOYSA-N 2-amino-n-(1-cyano-2-phenylethyl)acetamide Chemical compound NCC(=O)NC(C#N)CC1=CC=CC=C1 QLVGHFBUSGYCCG-UHFFFAOYSA-N 0.000 description 1
- 229940126650 Compound 3f Drugs 0.000 description 1
- 125000002974 D-tyrosino group Chemical group [H]OC(=O)[C@]([H])(N([H])[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- XJTWGMHOQKGBDO-GOSISDBHSA-N N-[(3-Fluorophenyl)methyl]-1-[(1r)-1-Naphthalen-1-Ylethyl]piperidine-4-Carboxamide Chemical compound C1CN([C@H](C)C=2C3=CC=CC=C3C=CC=2)CCC1C(=O)NCC1=CC=CC(F)=C1 XJTWGMHOQKGBDO-GOSISDBHSA-N 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 1
- 229940125796 compound 3d Drugs 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical class OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
本发明属于化学制药和精细化工制备技术领域,具体涉及一种钯催化剂脱氢偶联合成烯酰胺的方法。其主要技术方案如下:采用醋酸钯作为催化剂在氧化剂的共同作用下,使2‑吡啶酮类化合物与丙烯酸衍生物发生脱氢偶联反应,得到烯酰胺。本发明提供的一种钯催化剂脱氢偶联合成烯酰胺的方法,原料廉价易得,产物收率高,反应条件温和,在化学制药和精细化工制备技术领域具有广泛应用。
Description
技术领域
本发明属于化学制药和精细化工制备技术领域,具体涉及一种钯催化剂脱氢偶联合成烯酰胺的方法。
背景技术
烯酰胺类化合物是一类重要的含氮化合物。其在许多天然产物和药物活性分子中广泛存在(Chem.Rev.2003,103,4283;J.Am.Chem.Soc.2006,128,12954)。如altamide,lansiumamide A,lansiumamide B,salicyhalamide A,crocacin A等。同时也可用于合成具有生物活性的杂环、氨基酸以及手性胺等(Acc.Chem.Res.2000,33,363;J.Am.Chem.Soc.2001,123,9708)。
目前,从2-吡啶酮出发合成烯酰胺的方法主要有以下几种:
1)在强碱条件下,与卤代烯烃发生亲核取代反应合成烯酰胺(Tetrahedron,1978,34,2609)。如下式。
2)在碱性条件下,与丙炔酸衍生物发生加成反应合成烯酰胺(J.Chem.Res.2007,7,397;J.Org.Chem.2013,78,5832)。
上述两种方法中,第一种合成路线的产率较低,并且需要预先制备卤代烯烃,原子经济性不高,且该反应需要在强碱条件下进行,底物适用性较窄。第二种所用的丙炔酸类化合物适用性窄且价格高。
有鉴于上述现有的烯酰胺的合成方法中存在的缺陷,本发明人基于从事此类产品设计制造多年丰富的实务经验及专业知识,并配合学理的运用,积极加以研究创新,以期创设一种钯催化剂脱氢偶联合成烯酰胺的方法,原料廉价易得,产物收率高,反应条件温和,在化学制药和精细化工制备技术领域具有广泛应用。经过不断的研究、设计,并经反复试作样品及改进后,终于创设出确具实用价值的本发明。
发明内容
本发明的目的是提供一种钯催化剂脱氢偶联合成烯酰胺的方法,以2-吡啶酮和丙烯酸衍生物为原料,在钯催化剂和氧化剂共同作用下,发生脱氢偶联反应合成了烯酰胺。此方法原料廉价易得,反应条件温和,产率较高,在化学制药和精细化工制备技术领域具有广泛应用。
本发明的上述技术目的是通过以下技术方案得以实现的:
本发明提供的一种钯催化剂脱氢偶联合成烯酰胺的方法,采用醋酸钯作为催化剂在氧化剂的共同作用下,使2-吡啶酮类化合物与丙烯酸衍生物发生脱氢偶联反应,得到烯酰胺。
进一步的,本发明采用的2-吡啶酮类化合物的通式如下:
进一步的,本发明采用的丙烯酸衍生物的通式如下:
进一步的,本发明采用的合成路线的反应方程式如下所示:
进一步的,本发明采用的芳氧基包括但不限于是苯氧基、萘氧基或乙烯氧基中的任意一种,其中苯氧基、萘氧基或乙烯氧基可以是含有各种取代基的苯氧基、萘氧基、乙烯氧基。
进一步的,本发明采用的氨基还包括各种烷基取代的氨基或各种芳基取代的氨基。
进一步的,本发明合成烯酰胺的方法具体包括如下操作:将2-吡啶酮类化合物和丙烯酸衍生物溶于有机溶剂中,加入醋酸钯和氧化剂,加热并搅拌,之后将反应液用硅藻土抽滤,滤液浓缩后经柱层析色谱分离纯化得到烯酰胺产物,在本发明中,硅藻土抽滤用来去掉反应体系里面的金属盐,方便后面分离纯化,可以用柱层析硅胶代替。
进一步的,本发明中采用的氧化剂包括但不仅限于硝酸银、三氟乙酸银、醋酸银、碳酸银或磷酸银,还可以是其他的金属盐。本发明中,添加氧化剂的目的是为了实现催化循环,提高催化剂醋酸钯的催化性能,只需要加入0.1当量即可实现高效反应。
进一步的,本发明采用的有机溶剂是叔丁醇、1,2-二氯乙烷、氯仿、乙酸乙酯、甲苯、二甲苯、三甲苯、氯苯、二氯甲烷或1,4-二氧六环中的任意一种。
进一步的,加热的温度为40~100℃。
进一步的,2-吡啶酮类化合物的加入量为0.05~0.3mol。
综上所述,本发明具有以下有益效果:
本发明提供的以2-吡啶酮和丙烯酸衍生物为原料,在钯催化剂和氧化剂共同作用下,发生脱氢偶联反应合成了烯酰胺。此方法原料廉价易得,反应条件温和,产率较高,在化学制药和精细化工制备技术领域具有广泛应用。
具体实施方式
为更进一步阐述本发明为达成预定发明目的所采取的技术手段及功效,对依据本发明提出的一种钯催化脱氢偶联合成烯酰胺的方法,其具体实施方式、特征及其功效,详细说明如后。
实施例1:
将38mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3a,其分子结构为:其为黄色固体,70%产率。1H NMR(400MHz,CDCl3)δ8.51-8.47(d,J=14.7Hz,1H),7.44-7.41(dd, J1=7.2,J2=2.0Hz,1H),7.34-7.30(td,J1=9.4,J2=2.0Hz,1H),6.60-6.58(d,J=9.4Hz, 1H),6.25(t,J=6.2Hz,1H),6.13-6.09(d,J=14.7Hz,1H),3.80(s,3H);13C NMR(100 MHz,CDCl3)δ166.4,161.0,140.2,138.9,131.4,122.5,108.4,107.7,52.0 ppm.HRMS(ESI)C9H10NO3[M+H]+:理论值180.0655,实测值180.0655。
实施例2
将56.5mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3b,其分子结构为:其为黄色固体,62%产率。1H NMR(400MHz,CDCl3):δ8.45-8.41(d,J=14.6Hz,1H),8.32 -8.29(dd,J1=7.4Hz,J2=1.5Hz,1H),7.83-7.81(dd,J1=7.0Hz,J2=1.4Hz,1H), 6.45(t,J=7.2Hz,1H),6.30-6.27(d,J=14.6Hz,1H),3.83(s,3H);13C NMR(75MHz, CDCl3):δ165.5,153.1,140.3,138.9,138.1,138.1,112.3,105.0,52.5ppm.HRMS(ESI) C9H9N2O5[M+H]+:理论值225.0506,实测值225.0492。
实施例3
将56.5mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3c,其分子结构为:其为黄色固体,80%产率。1H NMR(400MHz,CDC3)δ8.75(d,J=3.0Hz,1H),8.40-8.36 (d,J=14.6Hz,1H),8.11-8.08(dd,J1=10.2,J2=3.0Hz,1H),6.67-6.64(d,J=10.2Hz, 1H),6.38-6.34(d,J=14.6Hz,1H),3.84(s,3H);13C NMR(125MHz,CDCl3)δ 165.3,159.4,137.8,133.8,133.5,132.2,121.4,112.3,52.5ppm.HRMS(ESI) C9H9N2O5[M+H]+:理论值225.0506,实测值225.0492。
实施例4
将65.3mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3d,其分子结构为:其为黄色固体,64%产率。1H NMR(500MHz,CDCl3):δ8.42-8.39(d,J=14.7Hz,1H),7.77 -7.76(dd,J1=6.8Hz,J2=0.5Hz,1H),7.69-7.68(dd,J1=7.2Hz,J2=1.5Hz,1H), 6.37(t,J=7.1Hz,1H),6.24-6.21(d,J=14.7Hz,1H);13C NMR(125MHz,CDCl3):δ 165.9,156.9,139.8,139.7,138.1,135.8,110.5,105.8,52.2ppm.HRMS(ESI) C10H9F3NO3[M+H]+:理论值248.0529,实测值248.0515。
实施例5
将51.8mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3e,其分子结构为:其为黄色固体,74%产率。1HNMR(400MHz,DMSO-d6):δ8.30-8.26(d,J=14.7Hz,1H), 8.07-8.06(d,J=7.0Hz,1H),7.80(t,J=6.2Hz,1H),6.62-6.58(d,J=14.7Hz,1H), 6.37(t,J=7.2Hz,1H),3.73(s,3H);13CNMR(100MHz,DMSO-d6):δ166.1,156.8, 139.2,138.3,132.4,125.3,109.3,106.8,51.8ppm.HRMS(ESI)C9H9ClNO3[M+H]+:理论值214.0266,实测值214.0246。
实施例6
将51.8mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3f,其分子结构为:其为黄色固体,71%产率。1H NMR(500MHz,CDCl3):δ8.38-8.35(d,J=14.7Hz,1H),7.42- 7.40(d,J=7.7Hz,1H),6.62-6.61(d,J=2.1Hz,1H),6.28-6.26(dd,J1=7.6Hz,J2= 2.1Hz,1H),6.13-6.10(d,J=14.7Hz,1H),3.76(s,3H);13C NMR(125MHz,CDCl3):δ 166.1,159.7,147.9,138.1,131.8,120.6,109.8,109.0,52.1ppm.HRMS(ESI) C9H9ClNO3[M+H]+:理论值214.0266,实测值214.0244。
实施例7
将51.8mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3g,其分子结构为:其为黄色固体,74%产率。1HNMR(400MHz,CDCl3):δ8.44-8.40(d,J=14.7Hz,1H),7.49 (d,J=2.6Hz,1H),7.30-7.27(dd,J1=9.9Hz,J2=2.7Hz,1H),6.60-6.58(d,J=9.9 Hz,1H),6.11-6.08(d,J=14.7Hz,1H),3.81(s,3H);13C NMR(125MHz,CDCl3):δ 166.1,159.4,141.4,138.1,128.9,123.4,115.0,108.9,52.2ppm.HRMS(ESI) C9H9ClNO3[M+H]+:理论值214.0266,实测值214.0244。
实施例8
将69.6mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3h,其分子结构为:其为黄色固体,60%产率。1H NMR(500MHz,CDCl3):δ8.37-8.34(d,J=14.7Hz,1H),7.33 -7.32(d,J=7.6Hz,1H),6.84-6.83(d,J=1.8Hz,1H),6.40-6.38(dd,J1=7.6Hz,J2=1.8Hz,1H),6.14-6.11(d,J=14.7Hz,1H),3.76(s,3H);13C NMR(125MHz,CDCl3):δ 166.1,159.4,138.2,136.9,131.4,124.2,112.2,109.0,52.1ppm.HRMS(ESI) C9H9BrNO3[M+H]+:理论值257.9761,实测值257.9735。
实施例9
将45.2mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入145μL丙烯酸甲酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3i,其分子结构为:其为黄色固体,70%产率。1HNMR(500MHz,CDCl3):δ8.44-8.41(d,J=14.7Hz,1H),7.30- 7.26(m,1H),7.09-7.05(m,1H),6.22-6.19(m,1H),6.18-6.15(d,J=14.7Hz,1H),3.78 (s,3H);13C NMR(100MHz,CDCl3):δ166.1,155.4,155.1,153.9,151.4,138.0,127.1, 127.1,120.1,120.0,109.6,105.6,105.6,52.1ppm.HRMS(ESI)C9H9FNO3[M+H]+:理论值198.0561,实测值198.0546。
实施例10
将38mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入253μL丙烯酸环己基酯,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3j,其分子结构为:其为黄色固体,65%产率。1H NMR(400MHz,CDCl3)δ8.46(d,J=14.7Hz,1H),7.43(d,J= 7.3Hz,1H),7.33-7.26(td,J1=8.8,J2=2.0Hz,1H),6.59(d,J=9.3Hz,1H),6.23(td,J1= 6.9,J2=1.3Hz,1H),6.10(d,J=14.7Hz,1H),4.87(m,1H),1.81(m,4H),1.63–1.12(m, 7H);13C NMR(100MHz,CDCl3)δ165.43,161.13,140.15,138.55,131.62,122.60, 109.72,107.63,73.44,31.75,25.44,23.89ppm.HRMS(ESI)C14H18NO3[M+H]+:理论值 248.1281,实测值248.1263。
实施例11
将38mg9mg醋酸钯和176.7mg三氟乙酸银加入到1mL 1,2-二氯乙烷中,再加入165μL N,N-二甲基丙烯酰胺,在60℃油浴下反应24h,之后用硅藻土过滤,浓缩,残留物经柱层析色谱分离得到化合物3k,其分子结构为:其为红色固体,81%产率。1H NMR(400MHz,CDCl3):δ8.04(d,J=13.8Hz,1H),7.53– 7.33(m,1H),7.30(dd,J=9.2,6.7Hz,1H),7.08(d,J=13.8Hz,1H),6.58(d,J=9.3Hz, 1H),6.22(t,J=6.8Hz,1H),3.08(d,J=34.7Hz,6H).13C NMR(100MHz,CDCl3);δ 165.99,162.03,139.45,138.72,134.14,122.62,110.79,107.29,37.68,36.01 ppm.HRMS(ESI)C14H18NO3[M+H]+:理论值193.0971,实测值193.0971。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的技术内容做出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。
Claims (10)
1.一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,采用醋酸钯作为催化剂在氧化剂的共同作用下,使2-吡啶酮类化合物与丙烯酸衍生物发生脱氢偶联反应,得到烯酰胺。
4.根据权利要求3所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述芳氧基是苯氧基、萘氧基或乙烯氧基中的任意一种。
5.根据权利要求3所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述氨基还包括烷基取代的氨基或芳基取代的氨基。
6.根据权利要求1所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,具体包括如下操作:将2-吡啶酮类化合物和丙烯酸衍生物溶于有机溶剂中,加入醋酸钯和氧化剂,加热并搅拌,之后将反应液用硅藻土抽滤,滤液浓缩后经柱层析色谱分离纯化得到烯酰胺产物。
7.根据权利要求6所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述氧化剂是硝酸银、三氟乙酸银、醋酸银、碳酸银或磷酸银中的任意一种。
8.根据权利要求6所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述有机溶剂是叔丁醇、1,2-二氯乙烷、氯仿、乙酸乙酯、甲苯、二甲苯、三甲苯、氯苯、二氯甲烷或1,4-二氧六环中的任意一种。
9.根据权利要求6所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述加热的温度为40~100℃。
10.根据权利要求6所述的一种钯催化剂脱氢偶联合成烯酰胺的方法,其特征在于,所述2-吡啶酮类化合物的加入量为0.05~0.3mol。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110873327.XA CN114014802B (zh) | 2021-07-30 | 2021-07-30 | 一种钯催化剂脱氢偶联合成烯酰胺的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110873327.XA CN114014802B (zh) | 2021-07-30 | 2021-07-30 | 一种钯催化剂脱氢偶联合成烯酰胺的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114014802A true CN114014802A (zh) | 2022-02-08 |
CN114014802B CN114014802B (zh) | 2023-11-28 |
Family
ID=80054230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110873327.XA Active CN114014802B (zh) | 2021-07-30 | 2021-07-30 | 一种钯催化剂脱氢偶联合成烯酰胺的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114014802B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115197037A (zh) * | 2022-06-30 | 2022-10-18 | 大连理工大学 | 一种丙烯酰胺以及三唑-烯酰胺交替共聚物的制备方法 |
-
2021
- 2021-07-30 CN CN202110873327.XA patent/CN114014802B/zh active Active
Non-Patent Citations (10)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115197037A (zh) * | 2022-06-30 | 2022-10-18 | 大连理工大学 | 一种丙烯酰胺以及三唑-烯酰胺交替共聚物的制备方法 |
CN115197037B (zh) * | 2022-06-30 | 2023-11-28 | 大连理工大学 | 一种丙烯酰胺以及三唑-烯酰胺交替共聚物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114014802B (zh) | 2023-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114195711B (zh) | 一种喹啉-4(1h)-酮化合物的制备方法 | |
CN113666862A (zh) | 一种通过镍催化不对称硝化反应制备手性3-硝基吲哚类化合物的方法 | |
CN114014802B (zh) | 一种钯催化剂脱氢偶联合成烯酰胺的方法 | |
CN114539198A (zh) | 一种含有(异)色满结构的酰胺化合物的制备方法 | |
CN108148070B (zh) | 一种呋喃酮并异喹啉酮类化合物的合成方法 | |
CN105949118A (zh) | 一种2-芳基喹啉衍生物的制备方法 | |
CN112724168B (zh) | 手性吡啶衍生的n,b配体及制备方法和在铱催化不对称硼化反应中的应用 | |
CN113045503B (zh) | 一种2-三氟甲基取代的喹唑啉酮化合物的制备方法以及在合成药物分子中的应用 | |
CN112694430B (zh) | 一种1,5-二氢-2h-吡咯-2-酮化合物的制备方法 | |
CN115215814A (zh) | 异恶唑烷类化合物的合成方法 | |
CN107973755B (zh) | 一种3-乙酰氨基喹喔啉酮衍生物的制备方法 | |
Sun et al. | Highly diastereoselective and enantioselective addition of organometallic reagents to a chiral C2-symmetrical bisimine | |
CN112239456B (zh) | 一种取代2,3-二氢喹诺酮化合物的制备方法 | |
CN111004164A (zh) | 一种多取代2-芳基吲哚衍生物的制备方法 | |
CN113735826B (zh) | 一种3-亚苄基-2,3-二氢喹诺酮化合物的制备方法 | |
CN113754544B (zh) | 一种多取代(e)-三氟甲基烯烃的制备方法 | |
CN115286628B (zh) | 一种吲哚并[2,1a]异喹啉化合物的制备方法 | |
CN114805127B (zh) | 一种2-三氟甲基-1-四氢萘酮化合物的制备方法 | |
CN111410656B (zh) | 一种异喹啉酮类衍生物的制备方法 | |
CN114160206B (zh) | 一种催化合成光学活性吲哚类化合物的催化剂、应用、合成方法及光学活性吲哚类化合物 | |
CN115246786B (zh) | 一种吲哚化合物或苯并恶嗪化合物的制备方法 | |
CN109331868B (zh) | 一种苯甘氨酸类双官能团催化剂及其制备方法和应用 | |
CN113429424B (zh) | 一种[1,2,4]噁二嗪并吲哚啉-3-酮衍生物的制备方法 | |
CN109721590B (zh) | 一种钴催化制备C2α酰氧基吲哚的方法 | |
CN110467558B (zh) | 一种镍催化合成3-胺基异吲哚啉酮的反应方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |